Clinical relevance of intrahepatic hepatitis B virus DNA in HBsAG-negative HBcAB-positive patients undergoing hematopoietic stem cell transplantation for hematological malignancies [3]

Transplantation

Volumn 82, Issue 1, 2006, Pages 141-142

  Picardi, Marco ^a   De Rosa, Gennaro ^a   Selleri, Carmine ^a   Pane, Fabrizio ^a   Rotoli, Bruno ^a,c   Muretto, Pietro ^b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b SAN SALVATORE HOSPITAL   (Italy)

^c FEDERICO II UNIVERSITY HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS B SURFACE ANTIGEN; LAMIVUDINE; VIRUS DNA; HEPATITIS B ANTIBODY;

ACUTE LEUKEMIA; ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; AUTOLOGOUS STEM CELL TRANSPLANTATION; CHRONIC LEUKEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEMATOLOGIC MALIGNANCY; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; LETTER; LIVER BIOPSY; LIVER FAILURE; LYMPHOMA; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; TREATMENT OUTCOME; BLOOD; BLOOD DISEASE; CHEMISTRY; GENETICS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; ISOLATION AND PURIFICATION; LIVER; LIVER CELL; PATHOLOGY; VIROLOGY;

DNA, VIRAL; FEMALE; HEMATOLOGIC NEOPLASMS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HEPATOCYTES; HUMANS; LIVER; MALE;

EID: 33747502145     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.tp.0000225828.27850.fc     Document Type: Letter

References (10)

1. Lok AS, Liang RH, Chiu EK, et al. Reactivation of hepatitis B virus replication in patients receiving cytotoxic therapy. Report of a prospective study. Gastroenterology 1991; 100: 182.
2. Carpenter PA, Huang ML, McDonald GB. Activation of occult hepatitis B from a seronegative patient after hematopoietic cell transplant: a cautionary tale. Blood 2002; 99: 4245.
3. Stebbing J, Atkins M, Nelson M, et al. Hepatitis B reactivation during combination chemotherapy for AIDS-related lymphoma is uncommon and does not adversely affect outcome. Blood 2004; 103: 2431.
4. Chee-kin Hui, Albert Lie, Wing-yan Au, et al. A long-term follow-up study on hepatitis B surface antigen-positive patients undergoing allogeneic hematopoietic stem cell transplantation. Blood 2005; 106: 464.
5. Picardi M, Muretto P, De Rosa G, et al. Color ultrasound-guided fine needle cutting biopsy for the characterization of diffuse liver damage in critical bone marrow transplanted patients. Haematologica 2002; 87: 652.
6. Han KH, Hollinger B, Noonan CA, et al. Southern-blot analysis and simultaneous in situ detection of hepatitis B virus-associated DNA and antigens in patients with end-stage liver disease. Hepatology 1993; 18: 1032.
7. Loriot MA, Marcellin P, Walker F, et al. Persistence of hepatitis B virus DNA in serum and liver from patients with chronic hepatitis B after loss of HBsAg. J Hepatol 1997; 27: 251.
8. Gilbert N, Corden S, Ijaz S. Comparison of commercial assays for the quantification of HBV DNA load in health care workers: calibration differences. J Virol Methods 2002; 100: 37.
9. Ishak K, Baptista A, Bianchi L, et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995; 22: 696.
10. Pollicino T, Squadrito G, Cerenzia G, et al. Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection. Gastroenterolgy 2004; 126: 102.